November 4, 2016 / 7:36 AM / a month ago

BRIEF-Puretech Health Says Clinical Trial Initiated Of Wholly-Owned Candidate

March 3 (Reuters) - PureTech Health PLC:

* PURETECH HEALTH PLC - CLINICAL TRIAL INITIATED OF WHOLLY-OWNED CANDIDATE

* PURETECH HEALTH PLC - FIRST PARTICIPANT DOSED IN CLINICAL TRIAL OF WHOLLY-OWNED LYMPHOEDEMA CANDIDATE LYT-100

* PURETECH HEALTH - MANY ASCENDING DOSE, FOOD EFFECT STUDY WILL BE FOLLOW-UP TO PREVIOUSLY CONDUCTED SINGLE ASCENDING DOSE CLINICAL TRIAL OF LYT-100 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below